BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo WJ, Tian X, Xu WH, Qu YY, Zhu WK, Wu J, Ma CG, Zhang HL, Ye DW, Zhu YP. Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer. J Cell Mol Med 2021;25:4326-39. [PMID: 33797188 DOI: 10.1111/jcmm.16494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiao Y, Dong Y, Yu T, Wang R, Gao Y, Li S, Nong S, Li W. Characterization of the immune related lncRNAs in bladder cancer to aid immunotherapy. Front Immunol 2022;13:941189. [DOI: 10.3389/fimmu.2022.941189] [Reference Citation Analysis]
2 Tang D, Li Y, Tang Y, Zheng H, Luo W, Li Y, Li Y, Wang Z, Wu S. Recognition of Glycometabolism-Associated lncRNAs as Prognosis Markers for Bladder Cancer by an Innovative Prediction Model. Front Genet 2022;13:918705. [DOI: 10.3389/fgene.2022.918705] [Reference Citation Analysis]
3 Li X, Zhou L, Lu T, Zhang L, Li Y, Xu J, Yin M, Long H. Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer. J Clin Lab Anal 2022;:e24389. [PMID: 35421267 DOI: 10.1002/jcla.24389] [Reference Citation Analysis]
4 Xia Q, Zhang Y, Li L, Lu J, Xun Y, Sun J, Xu J, Liu C, Lu Y, He D, Wang S, Obaid A. Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/8131007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hou J, Liang S, Xie Z, Qu G, Xu Y, Yang G, Tang C. An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer. Sci Rep 2022;12:3225. [PMID: 35217715 DOI: 10.1038/s41598-022-07334-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luo W, Wang J, Dai X, Zhang H, Qu Y, Xiao W, Ye D, Zhu Y. ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer. Front Oncol 2021;11:754845. [PMID: 34868963 DOI: 10.3389/fonc.2021.754845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Luo W, Wang J, Xu W, Ma C, Wan F, Huang Y, Yao M, Zhang H, Qu Y, Ye D, Zhu Y. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell Death Dis 2021;12:1043. [PMID: 34728613 DOI: 10.1038/s41419-021-04296-1] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
8 Song S, Liu S, Wei Z, Jin X, Mao D, He Y, Li B, Zhang C. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer. Front Cell Dev Biol 2021;9:726716. [PMID: 34621744 DOI: 10.3389/fcell.2021.726716] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Cui Y, Zhou Z, Chai Y, Che X, Zhang Y. Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer. J Oncol 2021;2021:8533464. [PMID: 34484338 DOI: 10.1155/2021/8533464] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Luo WJ, Tian X, Xu WH, Qu YY, Zhu WK, Wu J, Ma CG, Zhang HL, Ye DW, Zhu YP. Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer. J Cell Mol Med 2021;25:4326-39. [PMID: 33797188 DOI: 10.1111/jcmm.16494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]